Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5569_Библиотеки_им_академика_М_И_Перельмана
.pdf
5 Babchi
https://t.me/medicina_free
111
5.11.18 DNA Polymerase andTopoisomerase II Inhibitors
In an activity directed isolation assay that resulted in the separation of novel compounds bakuchiol, corylifolin, resveratrol and neobavaisoavone, it was found that
the crude extract of P. corylifolia with solvent ethanol was a powerful DNA poly-
merase inhibitor of DNA replication enzyme. Daidzein and bakuchicin, two topoisomerase II inhibitors, were also discovered in a related enzyme assay [30].
5.11.19 Estrogenic Effects
Phytoestrogens are naturally occurring substances generated from plants that
resemble endogenous estrogens structurally and have estrogenic action. Moreover,
phytoestrogens have been linked to a number of biological processes, such as osteoporosis prevention, menopause syndrome relief, and the reduction of proliferative
and cardiovascular illnesses. It has been consistently observed that the phenolic
chemicals stilbenes, isoavones, lignans and coumestans have estrogenic effects
[65]. The estrogenic effects of many avonoids from P. corylifolia fruits is investi-
gated utilizing isoavones, avanones, and chalcones [66, 67]. The avonoids that
were put to the test were chalcones (bavachalcone, isobavachalcone, and
4′-Omethylbavachalcone), avanones (bavachin, isobavachin, and bavachinin), and
isoavones (corylin and neobavaisoavone). With the exception of corylin, which
lacked any binding potential, all of the examined avonoids in a uorescence polarisation assay demonstrated the ability to bind to the protein human oestrogen receptor ligand-binding domain (hERLBD) in a dose-dependent manner.
Neobavaisoavone demonstrated the highest binding capacity to hER-LBD among
the active avonoids [65]. Because corylin lacks estrogenic activity, a quantitative
structure-activity relationship (QSAR) analysis concluded that the presence of
hydroxyl and prenyl groups is necessary for the estrogenic activities of avonoid
compounds [67].
5.11.20 Osteoporosis andEstrogenic Activity
A metabolic bone disease called osteoporosis is characterized by decreasing bone
mass and deteriorating bone microstructure, which causes bone fragility [68].
Previous investigations have established the potential therapeutic use of P. corylifo-
lia in the treatment of osteoporosis. The osteogenic activity of neobavaisoavone,
which was isolated from P. corylifolia, was described. The activation of p38 and
subsequent upregulation of the transcription factors Runx2 and Osx are how it stimulates osteogenesis [69]. Furthermore, in glucocorticoid-induced osteoporosis rats,
ethanolic extract of P. corylifolia seeds signicantly controlled 18 possible
112
https://t.me/medicina_free
biomarkers connected to the etiology of osteoporosis. These biomarkers were discovered to be involved in the pathways for the metabolism of arginine, nicotinamide, and tryptophan [66]. Evidence for its possible therapeutic application in the
treatment of osteoporosis was provided by the inuence of P. corylifolia extract on
the regulation of several metabolic pathways and the related biomarkers. Corylin
from P. corylifolia fruits has been demonstrated to have osteogenic activity in addi-
tion to neobavaisoavone. Runx2, Osterix, Co11, and ALP found to be key osteogenesis biomarkers that were induced by corylin [70]. Its osteogenic activity
involved two pathways through oestrogen and Wnt/catenin signalling, indicating its
therapeutic promise for osteoblasts-mediated osteoporosis, according to a thorough
analysis of its mode of action.
Using various invitro assays, the estrogenic effects of the alcoholic extract and
its active ingredients from P. corylifolia L. were investigated. According to analysis
of the ethanol extract, bakuchiol, bavachinin, isobavachalcone, isobavachromene,
and psoralen were present. Hexane and chloroform fractions from a fractionation
process demonstrated estrogenic activity in a yeast transactivation experiment. At a
concentration of 1.0ng/ml, the ethanolic extracts demonstrated noticeably higher
activities, while bakuchiol demonstrated the highest activity, that was greater than
genistein at the same concentration in the yeast transactivation assay. Bakuchiol
demonstrated the maximum ER-binding capacity for ER α in the ER binding experiment, and it demonstrated a vefold stronger afnity for ER α than for ER β [36].
M. Azeem etal.
5.11.21 Immunomodulatory Activity
When tested in mice, the extract of P. corylifolia seeds was found to have stimulant
activity against natural killer cells. According to this study, the extract also regulates
antibody-dependent cellular toxicity [24].
5.11.22 Insecticidal andGenotoxic Activity
The southern house mosquito, Culex quinquefasciatus (earlier known as Culex fatigans), larvae and adults were highly susceptible to the extracted oil from the seeds
of P. corylifolia [71].
5.11.23 Inhibition ofLymph Angiogenesis
The bioactivity-guided fractioned compounds from the Psoraleae extract are angelicin, isobavachalone, p-hydroxybenzaldehyde, psoralen, bakuchiol hydroxybakuchiol and psoracorylifol, signicantly slowed down the growth of
5 Babchi
https://t.me/medicina_free
temperature-sensitive rat lymphatic endothelial (TRLE) cells invitro [6]. These
bioactive substances prevented TR-LE cell proliferation and the development of
capillary-like tubes. A concentration of 10μm of bakuchiol was used in the tube
emergence assay to analyze the cell cycle of TR-LE cells, and it was incubated for
6–48h [72]. Propodeum iodide was employed to stain after reaping. Some substances examined shown selectivity. The substances investigated may make promising candidates for the creation of lymph angiogenesis-blocking chemotherapy and
anti-metastatic medicines.
113
5.11.24 Neuroprotective Properties
P. corylifolia, which is used to treat a number of central nervous system problems,
incorporating neurotropic action and as an agent that maintains the central nervous
system, is a common ingredient in ayurvedic formulations [38]. The P. corylifolia
L. seed extract was the subject of a study based on this knowledge. Against the
cytotoxicity of 3 nitropropionic acid, the ndings demonstrated a potent protective
effect. The therapeutic potential of P. corylifolia seed extracts for neurological dis-
eases was identied in this study [40]. As a result, P. corylifolia Linn seed extracts
might be used therapeutically to treat neurological diseases.
5.11.25 Osteoblastic Activity
In vitro cultures of the UMR106 cell line revealed osteoblastic proliferationstimulating activity from P. corylifolia L. fruit extracts. According to a study, the
extract contained two avonoids, bavachin and corylin, which were found to be
effective against osteoporosis [28]. The bakuchiol as hepatoprotective molecule, as
well as two moderately active compounds, psoralen and bakuchicin on tacrineinduced cytotoxicity in human liver-derived Hep G-2 cells are analyzed from the
aqueous extract of P. corylifolia seed.
5.11.26 Skin Diseases Control
P. corylifolia seeds have been used for ages to treat a variety of skin conditions. In
keeping with its conventional uses, a number of clinical trials have also revealed
encouraging results from formulations made from the powdered seeds or natural
substances isolated from the seeds or fruits of P. corylifolia to treat dermatological
conditions like vitiligo and skin irritation [73]. When compared to retinal damage
caused by oxidative stress, the compounds from P. corylifolia were found to have a
protective effect [60]. In 2016, researchers ran a clinical trial to examine if a
114
https://t.me/medicina_free
hydrophilic ointment containing 10% w/w powdered P. corylifolia seeds might
affect the depigmentation of vitiligo patients. A skin ailment called vitiligo causes
white, pale patches to appear on the skin as a result of damaged cutaneous melanocytes, which affects the skin’s colour [74]. Many treatment plans for vitiligo have
been created, however none of them are truly effective cures.
Additionally, a cream formulation with 0.5% meroterpene phenol bakuchiol
extracted from P. corylifolia seeds was reported to have similar effects to retinol in
a double-blind, randomized clinical experiment in improving facial photoaging,
minimizing wrinkles, and lowering hyperpigmentation [75]. A total of 44 healthy
volunteers were included in the 12-week trial. Each set of participants got either a
face cream containing 0.5% bakuchiol or 0.5% retinol after being randomly assigned
to one of two groups. It has previously been reported that bakuchiol can activate
genes involved in the cellular uptake and stimulation of retinol as well as govern the
creation of extracellular matrix proteins, similar to what has previously been
described for retinol [76]. In addition to its capacity as a free radical scavenger,
bakuchiol increased cellular resilience to oxidative stress through activation of Nrf2
known as nuclear factor erythroid 2-related factor 2 [77]. These activities taken
together help bakuchiol’s antiaging properties.
The potential for bakuchiol and four other natural compounds isolated from
P. corylifolia seeds including psoralidin, psoralen, isopsoralen, and
8- methoxypsoralen to treat psoriasis-like lesions in an in vivo experiment was
investigated further [78]. It was discovered that isopsoralen and 8-methoxypsoralen
improved psoriasis-like lesions by reducing epidermal thickness, cytokine release,
and skin barrier deciencies brought on by UVA radiation. Ultimately, this result
suggested that isopsoralen, along with the well-known 8-methoxypsoralen, is a
good photosensitizing option for photochemotherapy against psoriasis-like lesions.
M. Azeem etal.
5.12 Industrial Applications
Psoralea corylifolia has a number of isolated chemicals that are commercially
available and have numerous industrial applications. The following are a few examples: Methoxsalen (CAS 298-81-7), also known as 8-Methoxypsoralen, is a powerful cytochrome P450 suicide inhibitor. There is an antifungal substance called
angelicin (CAS 523-50-2). Available as a mild antioxidant that promotes bone
growth is bavachin (CAS 19879-32-4) [79]. PTP1B and DNA polymerase inhibitors
are both accessible in the form of bakuchiol (CAS 10309-37-2). Genistein (CAS
44672-0), a substance, is a highly effective protein tyrosine kinase inhibitor [61].
The substance Daidzin (CAS 55266), which has been isolated from many plant species exhibits anti-chemotherapeutic properties and effective inhibitor of human
mitochondrial metabolic enzymes including aldehyde dehydrogenase [6, 80]. These
demonstrations plainly highlighted the signicance of bioactive substances extracted
from P. corylifolia, an indispensable traditional plant with pharmaceutical
applications.
5 Babchi
https://t.me/medicina_free
115
5.13 Clinical Studies
For a very long period, Psoralea species have been utilized in traditional medicine
and folklore. Many Psoralea products have been successfully manufactured and are
on the market. You can eat the parts of P. argophylla, also known as silvery leaf
Indian breadroot, fresh or cooked. Because the plant possesses analgesic qualities,
a poultice made from the roots is applied to sore body parts [1, 81]. Colds, coughs,
headaches, and sore throats can all be treated with a combination of the plants stem
and roots. In Chinese traditional medicine, Psoralea corylifolia L. (Bu Gu Zhi) is
renowned as a tonic that boosts general vitality. The plant has demonstrated efcacy
in the Unani system against skin conditions, high fever, and internal ulcers [1].
Due to the plant’s blood-purifying characteristics, it is used to cure ringworm
infection, boils, eruptions or red papules, itchy, severe eczema, rough and discolored dermatosis with scabies and ssures [82]. Streptococcal skin infection is said
to be strongly affected by the essential oil from the plant [83]. It also has a reputation for improving the hue of nails, hair, and skin. Seeds are described as being sour,
bitter, caustic, and astringent. Japan has used the ethanol extract of the seeds to
preserve pickles and other processed goods [1, 84].
Additionally, P. corylifolia fruits can be used medicinally. Since the seeds have
potent aphrodisiac properties, they are used as a tonic to strengthen the sexual
organs [1]. The fruits are known to improve complexion, have a bitter avor, and
help treat piles, bronchitis, anemia, and difculties urinating in addition to preventing vomiting [85]. Fruit extract also inhibit Mycobacterium tuberculosis growth
[86]. P. corylifolia seeds and roots are used to stop tooth decay. They are advanta-
geous for treating bone fractures and osteoporosis because they also induce bone
calcication [1].
The traditional remedy with P. corylifolia as its primary component was applied
locally to 30 vitiligo patients as part of a clinical experiment, in addition to taking
Gandhaka rasayana orally. Early vitiligo cases improved signicantly between 1 to
10months, however chronic cases of vitiligo on the lips responded poorly. Very
positive outcomes were obtained when 8-methoxypsoralen was taken orally and
exposed to sunshine for 5–30minutes each day for 1–7weeks. In a different study,
it was discovered that psoralen and its chemical compounds, particularly trioxalen,
work better as psoriasis treatments when combined with sun exposure. 49 patients
received P. corylifolia treatment for 6 months in one research. A further 19% of
these patients repaired at least two-thirds of the damaged skin’s pigmentation.,
while 14% of them were cured [87].
About 76 patients with grade II and III acne vulgaris between the ages of 16 and
24 participated in a clinical study. Patients were told to use Clarina cream as a topical treatment, as well as herb medicines Purim pills with P. corylifolia listed among
the ingredients. According to the ndings, people with the acne disease of grade II
had an incredible response in 56 percent of situations and a positive outcome in 43
percent of cases [8, 88].
116
https://t.me/medicina_free
M. Azeem etal.
5.14 Negative Impacts andCytotoxicity
In everyday life, the prospective hepatotoxicity of medicinal herbs is usually overlooked. Psoralea corylifolia seemed to be interconnected to the development of
acute cholestatic hepatotoxicity. Some alternative therapy research indicates that
P. corylifolia can treat osteoporosis. They discovered a specic instance of intense
cholestatic hepatitis in a post- menopausal woman who took more than ten times
the usual dose of P. corylifolia seeds [34]. A biopsy revealed region multiple tissue
damage, degenerating cells, cholestasis, and inammatory cell inltrations. This
case emphasizes the importance of warning about the prospective hepatotoxicity of
P. corylifolia seed particularly in large doses [6]. Psoralea has great bioactivities but
can have negative consequences if used excessively. It has been claimed that
Psoralea genus is harmful to horses and cattle, hence it is not advised for use as fodder. There have been reports of cutaneous allergic responses following the administration of oral and injectable Psoralea formulations [89]. Psoralea overdose
symptoms include lightheadedness, generalized weakness, blurred vision, fast
breathing, and vomiting. Blood has been spat out, people have lost consciousness,
and others have gone into a coma in severe overdose situations [90]. In a related
investigation, rats received various amounts of P. corylifolia solutions daily for
90days. The medication reduced body weight and reproductive organ weight (testes
and ovaries), showing reproductive toxicity caused by psoralen [91]. There are
numerous studies on the effects of long-term psoralen or isopsoralen use on the livers of mice and rats. The potential toxicity of P. corylifolia and its natural products
(neobavaisoavone, bavachin, and corylifol) was assessed in a study. According to
the ndings, it exhibited a signicant inhibitory effect on human UDPglucuronosyltransferase 1A1 (UGT1A1), a known stimulator of P. corylifoliarelated toxicity including liver damage and elevated bilirubin levels [92]. Three
occurrences of liver damage in Chinese people have been linked to eating dried
P. corylifolia seedlings. The tablets manufactured from P. corylifolia leaves were
determined to be the hepatotoxicity’s most likely culprit. The underlying hepatotoxic processes of P. corylifolia and its primary constituents, however, are not fully
understood [93, 94]. According to a book on traditional Chinese medicine, Psoralea
doesn’t have any negative side effects at doses within the typical range [89]. One
thing was discovered to be common to all case studies and research on psoraleainduced toxicity, and that is the deliberate and extended consumption of a high dose.
We may infer from the literature that is now available that there are differing views
regarding the toxicity caused by Psoralea, and as a result, there is still a study gap
regarding its method of action and its pharmacological standardization. The strongest inhibition against all examined cancer cell lines was seen with bakuchiol
among the tested meroterpenoids, and its novel cyclic counterparts did not exhibit
any cytotoxic effect [95]. This result shows that the meroterpenoid metabolites of
P. corylifolia have less cytotoxic effect due to side-chain cyclization. Moreover,
another subsequent chemical analysis of P. corylifolia fruits produced 17 meroter-
pene phenols, which were given the unimportant names psocorylins A–Q as the new
meroterpene analogues [96].
5 Babchi
https://t.me/medicina_free
117
5.15 Conclusion
The most signicant disorders that the belonging to the family Psoralea has the most
potential to treat are vitiligo, leprosy, and psoriasis. Pre-clinical research has shown
encouraging ndings, but further research is needed to fully understand the molecular processes behind the aforementioned pharmacological activities as well as to
assess the efcacy of isolated drugs in tests that are appropriately constructed.
Before the start of clinical trials, the estimated risk of extracts must also be established by long-term toxicity studies and information on drug interactions. The effectiveness and efciency of the bioactive substances found in the Psoralea genus have
occasionally been assessed. Since there is already knowledge of the medical benets supported by scientic evidence. Further investigation should concentrate on
bulk cultivation and the extraction of bioactive compounds. Millions of patients
with psoriasis, leprosy, and vitiligo will experience natural alleviation with the
development of pharmaceutical medications comprising psoralea as a sole or partial
constituent. It is abundantly obvious from reviewing the literature on the genus
Psoralea that P. corylifolia is a crucial component of a traditional biological, medici-
nal plant, phytoconstituents and ethnopharmacological point of view. This includes
guring out how many bioactive elements are present in each species. To sum up,
the Psoralea species have enormous potential to be a cure-all for many illnesses, so
protecting them before overusing them should be a precondition. Since olden days,
the plant has been used as a medicinal agent. The use of traditional herbal remedies
or their derivatives for preventative and curative purposes is becoming more popular
around the world. A thorough examination of the literature disclosed that P. coryli-
folia is a signicant indigenous herbal asset with a wide range of pharmacological
activities. Clinical studies have conrmed that it plays a signicant part in the prevention and control of a variety of diseases.
References
of the traditional and modern uses, phytochemistry and pharmacology. Journal of
Ethnopharmacology, 232, 201–226.
2. Farnsworth, N.R., Akerele, O., Bingel, A.S., Soejarto, D.D., & Guo, Z.J. (1985). Medicinal
plants in therapy. Bulletin of the World Health Organization, 63(6), 965.
3. Mehta, G., Nayak, U., & Dev, S. J. T. (1973). Meroterpenoids—I: Psoralea corylifolia
Linn.—1. bakuchiol, a novel monoterpene phenol. Tetrahedron, 29(8), 1119–1125.
4. Prasad, N.R., Anandi, C., Balasubramanian, S., & Pugalendi, K. (2004). Antidermatophytic
activity of extracts from Psoralea corylifolia (Fabaceae) correlated with the presence of a avonoid compound. Journal of Ethnopharmacology, 91(1), 21–24.
5. Masihuzzaman, A.M., Iftikhar, M.Y., Alia, B., & Farheen, K. (2022). Babchi (Psoralea corylifolia Linn.): an effective Unani medicine for dermatological disorders: A review. International
Journal of Unani and Integrative Medicine, 6(1), 17–21.
6. Shaikh, H.S., & Shaikh, S.S. (2021). Babchi (Psoralea corylifolia): From a variety of traditional medicinal application to its novel roles in various diseases: A review. Asian Journal of
Pharmacy and Technology, 11(3), 238–244.
118
https://t.me/medicina_free
7. Alam, F., Khan, G.N., & Asad, M.H. H.B. (2018). Psoralea corylifolia L: Ethnobotanical,
biological, and chemical aspects: a review. Phytotherapy Research, 32(4), 597–615.
8. Khushboo, P., Jadhav, V., Kadam, V., & Sathe, N. (2010). Psoralea corylifolia Linn.—
“Kushtanashini”. Pharmacognosy Reviews, 4(7), 69.
9. Farooqi, A. A., & Sreeramu, B. (2004). Cultivation of medicinal and aromatic crops.
Universities Press.
10. Joshi, A.R., & Joshi, K. (2000). Indigenous knowledge and uses of medicinal plants by local
communities of the Kali Gandaki Watershed Area, Nepal. Journal of Ethnopharmacology,
73(1–2), 175–183.
11. Santao, Y., Bin, Y., & Zhiling, X. (1995). Determination of bakuchiol in the fruit of Psoralea
corylifolia L. Zhongguo Zhong Yao Za Zhi, 20(11), 681–683.
12. Pandey, P., Mehta, R., & Upadhyay, R. (2013). Physico-chemical and preliminary phytochemical screening of Psoralea corylifolia. Archives of Applied Science Research, 5(2), 261–265.
13. Agharkar S.Medicinal plants of Bombay presidency. 1953.
14. Nadkarni, A. (1954). Nadkarni’s Indian Materia Medica.
15. Nadkarni, K., & Nadkarni, A.J. L. (1976). Bombay. Indian Materia Medica (Vol. 1, p.799).
Popular Prakashan Pvt.
16. Azhar, M., Naushin, S., & Alam, M. (2020). Zahar Mohra (Bezoar) an Alexipharmic Unani
mineral drug. Journal of Drug Delivery and Therapeutics, 10(6), 236–238.
17. Wang, T.-X., Yin, Z.-H., Zhang, W., Peng, T., & Kang, W.-Y. (2013). Chemical constituents
from Psoralea corylifolia and their antioxidant alpha-glucosidase inhibitory and antimicrobial
activities. China Journal of Chinese Materia Medica, 38(14), 2328–2333.
18. Bi, S., Akhtar, J., Bashir, F., & Alvi, R. (2020). Pharmacological investigations of Babchi
(Psoralea corylifolia Linn)– An important drug of Unani system of medicine. International
Journal of Unani and Integrative Medicine, 4(1), 32–36.
19. Kirtikar, K., & Basu, B. (1935). Indian medicinal plants. Lalit Mohan Publication.
20. Zhao, L., Huang, C., Shan, Z., Xiang, B., & Mei, L. (2005). Fingerprint analysis of Psoralea
corylifolia L. by HPLC and LC–MS. Journal of Chromatography B, 821(1), 67–74.
21. Büyükbalci, A., & El, S.N. (2008). Determination of invitro antidiabetic effects, antioxidant activities and phenol contents of some herbal teas. Plant Foods for Human Nutrition,
63, 27–33.
22. Aslan, M., Orhan, N., Orhan, D.D., & Ergun, F. (2010). Hypoglycemic activity and antioxidant potential of some medicinal plants traditionally used in Turkey for diabetes. Journal of
Ethnopharmacology, 128(2), 384–389.
23. Limper, C., Wang, Y., Ruhl, S., Wang, Z., Lou, Y., Totzke, F., etal. (2013). Compounds isolated
from Psoralea corylifolia seeds inhibit protein kinase activity and induce apoptotic cell death
in mammalian cells. Journal of Pharmacy and Pharmacology, 65(9), 1393–1408.
24. Latha, P., Evans, D., Panikkar, K., & Jayavardhanan, K. (2000). Immunomodulatory and antitumour properties of Psoralea corylifolia seeds. Fitoterapia, 71(3), 223–231.
25. Tang, S.Y., Whiteman, M., Peng, Z.F., Jenner, A., Yong, E.L., Halliwell, B., et al. (2004).
Characterization of antioxidant and antiglycation properties and isolation of active ingredients
from traditional Chinese medicines. Free Radical Biology and Medicine, 36(12), 1575–1587.
26. Chen, X., Yang, Y., & Zhang, Y. (2013). Isobavachalcone and bavachinin from Psoraleae
Fructus modulate Aβ42 aggregation process through different mechanisms in vitro. FEBS
Letters, 587(18), 2930–2935.
27. Chopra, B., Dhingra, A.K., & Dhar, K.L. (2013). Psoralea corylifolia L. (Buguchi)– Folklore
to modern evidence. Fitoterapia, 90, 44–56.
28. Wang, D., Li, F., & Jiang, Z. (2001). Osteoblastic proliferation stimulating activity of Psoralea
corylifolia extracts and two of its avonoids. Planta Medica, 67(08), 748–749.
29. Bhawya, D., & Anilakumar, K. (2011). Antioxidant, DNA damage protection and antibacterial
effect of Psoralea corylifolia. Asian Journal of Pharmaceutical and Clinical Research, 4(2),
149–155.
M. Azeem etal.
5 Babchi
https://t.me/medicina_free
30. Sun, N.J., Woo, S.H., Cassady, J.M., & Snapka, R.M. (1998). DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. Journal of Natural Products, 61(3), 362–366.
31. Borate, A., Udgire, M., & Khambhapati, A. (2014). Antifungal activity associated with
Psoralea corylifolia Linn. (Bakuchi) seeds and chemical prole crude methanol seed extract.
Mintage Journal of Pharmaceutical and Medical Sciences, 3(3), 4–6.
32. Yin, S., Fan, C.-Q., Wang, Y., Dong, L., & Yue, J.-M. (2004). Antibacterial prenylavone derivatives from Psoralea corylifolia, and their structure–activity relationship study. Bioorganic &
Medicinal Chemistry, 12(16), 4387–4392.
33. Kaufman, P.B., Duke, J.A., Brielmann, H., Boik, J., & Hoyt, J.E. (1997). A comparative survey of leguminous plants as sources of the isoavones, genistein and daidzein: Implications for
human nutrition and health. Journal of Alternative and Complementary Medicine, 3(1), 7–12.
34. Toyooka, T., & Ibuki, Y. (2009). Histone deacetylase inhibitor sodium butyrate enhances the
cell killing effect of psoralen plus UVA by attenuating nucleotide excision repair. Cancer
Research, 69(8), 3492–3500.
35. Kamboj, J., Sharma, S., & Kumar, S. (2011). In vivo Anti-diabetic and Anti-oxidant potential
of Psoralea corylifolia seeds in Streptozotocin induced type-2 diabetic rats. Journal of Health
Science, 57(3), 225–235.
36. Lim, S.-H., Ha, T.-Y., Ahn, J., & Kim, S. (2011). Estrogenic activities of Psoralea corylifolia
L. seed extracts and main constituents. Phytomedicine, 18(5), 425–430.
37. Jeong, D., Watari, K., Shirouzu, T., Ono, M., Koizumi, K., Saiki, I., et al. (2013). Studies
on lymphangiogenesis inhibitors from Korean and Japanese crude drugs. Biological and
Pharmaceutical Bulletin, 36(1), 152–157.
38. Goel, S., & Ojha, N.K. (2015). Ashtang Ghrita: A noble Ayurveda drug for central nervous
system. Journal of Ayurveda and Holistic Medicine, 3(2), 18–24.
39. Ling, F., Lu, C., Tu, X., Yi, Y., Huang, A., Zhang, Q., et al. (2013). Antiprotozoal screening of traditional medicinal plants: Evaluation of crude extract of Psoralea corylifolia against
Ichthyophthirius multiliis in goldsh. Parasitology Research, 112, 2331–2340.
40. Im, A., Chae, S.-W., & Lee, M.-Y. (2014). Neuroprotective effects of Psoralea corylifolia
Linn seed extracts on mitochondrial dysfunction induced by 3-nitropropionic acid. BMC
Complementary and Alternative Medicine, 14(1), 1–8.
41. Xu, Q., Pan, Y., Yi, L.-T., Li, Y.-C., Mo, S.-F., Jiang, F.-X., etal. (2008). Antidepressant-like
effects of psoralen isolated from the seeds of Psoralea corylifolia in the mouse forced swimming test. Biological & Pharmaceutical Bulletin, 31(6), 1109–1114.
42. Gidwani, B., Alaspure, R., Duragkar, N., Singh, V., Rao, S.P., & Shukla, S. (2010). Evaluation
of a novel herbal formulation in the treatment of eczema with Psoralea corylifolia. Iranian
Journal of Dermatology, 13, 122–127.
43. Shilaskar, D., & Parasar, G. (1985). Studies on effect of Psoralea corylifolia and Piper betle on
cholinesterase and succinic dehydrogenase enzymes as possible targets of their anthelmintic
action. The Indian Veterinary Journal, 62, 557–562.
44. Iwamura, J., Dohi, T., Tanaka, H., Odani, T., & Kubo, M. (1989). Cytotoxicity of corylifoliae fructus. II.Cytotoxicity of bakuchiol and the analogues. Pharmaceutical Science Journal,
109(12), 962–965.
45. Won, T.H., Song, I.-H., Kim, K.-H., Yang, W.-Y., Lee, S.K., Oh, D.-C., etal. (2015). Bioactive
metabolites from the fruits of Psoralea corylifolia. Journal of Natural Products, 78(4),
666–673.
46. Li, H.-N., Wang, C.-Y., Wang, C.-L., Chou, C.-H., Leu, Y.-L., Chen, B.-Y., et al. (2019).
Antimicrobial effects and mechanisms of ethanol extracts of Psoralea corylifolia seeds
against Listeria monocytogenes and methicillin-resistant Staphylococcus aureus. Foodborne
Pathogens and Disease, 16(8), 573–580.
47. Husain, F.M., Ahmad, I., Khan, F.I., Al-Shabib, N.A., Baig, M.H., Hussain, A., etal. (2018).
Seed extract of Psoralea corylifolia and its constituent bakuchiol impairs AHL-based quorum
sensing and biolm formation in food-and human-related pathogens. Frontiers in Cellular and
Infection Microbiology, 8, 351.
119
120
https://t.me/medicina_free
48. Rutherford, S., & Bassler, B. (2012). Quorum sensing: Its role in virulence and possibilities for
its control. Cold Spring Harbor Perspectives in Medicine, 2(11), 1.
49. Asad, M. H. H. B., Durr-e-Sabih, Choudary, B.A., Asad, A. F., Muratza, G., & Hussain,
I. (2014). Compensatory effects of medicinal plants of Pakistan upon prolongation of coagulation assays induced by Naja naja karachiensis bite. Current Science, 106, 870–873.
50. Asad, M.H. H.B., Razi, M.T., Durr-e-Sabih, Najamus-Saqib, Q., Nasim, S.J., Murtaza, G.,
etal. (2013). Anti-venom potential of Pakistani medicinal plants: Inhibition of anticoagulation
activity of Naja naja karachiensis toxin. Current Science, 1419–1424.
51. Farahani, M.S., Bahramsoltani, R., Farzaei, M.H., Abdollahi, M., & Rahimi, R. (2015). Plantderived natural medicines for the management of depression: An overview of mechanisms of
action. Reviews in the Neurosciences, 26(3), 305–321.
52. Ghosh, D., Bera, T., Chatterjee, K., Ali, K., & Debasis, D. (2009). Antidiabetic and antioxidative effects of aqueous extract of seed of Psoralea corylifolia (somraji) and seed of Trigonella
foenum-graecum L., (methi) in Separate and composite manner in streptozotocin-induced diabetic male Albino rat. International Journal of Pharmaceutical Research and Development,
1(7), 1–10.
53. Lee, H., Li, H., Noh, M., & Ryu, J.-H. (2016). Bavachin from Psoralea corylifolia improves
insulin-dependent glucose uptake through insulin signaling and AMPK activation in 3T3-L1
adipocytes. International Journal of Molecular Sciences, 17(4), 527.
54. Seo, E., Oh, Y.S., & Jun, H.-S. (2016). Psoralea corylifolia L. seed extract attenuates nonalcoholic fatty liver disease in high-fat diet-induced obese mice. Nutrients, 8(2), 83.
55. Zhu, G., Luo, Y., Xu, X., Zhang, H., & Zhu, M. (2019). Anti-diabetic compounds from the
seeds of Psoralea corylifolia. Fitoterapia, 139, 104373.
56. He, S., Hong, Q., Lai, Z., Yang, D.X., Ting, P.C., Kuethe, J.T., etal. (2014). Discovery of
a potent and selective DGAT1 inhibitor with a piperidinyl-oxy-cyclohexanecarboxylic acid
moiety. ACS Medicinal Chemistry Letters, 5(10), 1082–1087.
57. Liu, J., Zhao, Y., Huang, C., Li, Y., & Guo, F. (2019). Prenylated avonoid-standardized extract
from seeds of Psoralea corylifolia L. activated fat browning in high-fat diet–induced obese
mice. Phytotherapy Research, 33(7), 1851–1864.
58. Chai, M.-Y. (2019). A new bioactive coumestan from the seeds of Psoralea corylifolia. Journal
of Asian Natural Products Research, 22(3), 295–301.
59. Hosamani, A., Lakshman, H.C., & Sandeepkumar, K. (2012). Antimicrobial activity of leaf
extract of Psoralea corylifolia L. Life Sciences Leaets, 30, 35–39.
60. Kim, K.-A., Shim, S.H., Ahn, H.R., & Jung, S.H. (2013). Protective effects of the compounds isolated from the seed of Psoralea corylifolia on oxidative stress-induced retinal damage. Toxicology and Applied Pharmacology, 269(2), 109–120.
61. Behloul, N., & Wu, G. (2013). Genistein: A promising therapeutic agent for obesity and diabetes treatment. European Journal of Pharmacology, 698(1–3), 31–38.
62. Anusha, S., Haja Sherief, S., Sindhura, S., Jaya Preethi, P., & Siva Kumar, T. (2013).
Synergistic effet of indigenous medicinal plant extracts on Psoriasis. International Journal of
Phytopharmacy, 3(1), 23–29.
63. Rajendra Prasad, N., Anandi, C., Balasubramanian, S., & Pugalendi, K. V. (2004).
Antidermatophytic activity of extracts from Psoralea corylifolia (Fabaceae) correlated with
the presence of a avonoid compound. Journal of Ethnopharmacology, 91(1), 21–24. https://
doi.org/10.1016/j.jep.2003.11.010
64. Kim, D.W., Seo, K.H., Curtis-Long, M.J., Oh, K.Y., Oh, J.-W., Cho, J.K., etal. (2014).
Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds
of Psoralea corylifolia. Journal of Enzyme Inhibition and Medicinal Chemistry, 29(1), 59–63.
65. Desmawati, D., & Sulastri, D. (2019). Phytoestrogens and their health effect. Open Access
Macedonian Journal of Medical Sciences, 7(3), 495.
66. Zhao, F.-J., Zhang, Z.-B., Ma, N., Teng, X., Cai, Z.-C., & Liu, M.-X. (2019). Untargeted
metabolomics using liquid chromatography coupled with mass spectrometry for rapid discovery of metabolite biomarkers to reveal therapeutic effects of Psoralea corylifolia seeds against
osteoporosis. RSC Advances, 9(61), 35429–35442.
M. Azeem etal.
Соседние файлы в папке Библиотека им академика М.И. Перельмана